Heather Lau
Neurology with Special Qualifications in Child Neurology · New York, NYNPI 1164628053
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $73,239 of the $102,821 with a category attached, or 71.2%. 7 manufacturers reported payments, led by Sanofi at 55.8% of the total. Reporting peaked in 2019 at $42,753 and has fallen 97.1% since, to $1,250 in 2024. Among neurology with special qualifications in child neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $1904.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$57K
- Takeda Pharmaceuticals U.S.A., Inc.$24K
- Shire North American Group Inc$15K
- Amicus Therapeutics, Inc.$4K
- Bioverativ Therapeutics Inc.$2K
- Ultragenyx Pharmaceutical Inc.$400
- plus $23 from 1 others
Across 231 payments — averaging $7141.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$785K
- Amicus Therapeutics, Inc.$327K
- Sanofi US Services Inc.$168K
- Ultragenyx Pharmaceutical Inc.$158K
- Shire North American Group Inc$59K
- Biomarin Pharmaceutical Inc.$58K
- plus $95K from 5 others
What the payments were for
- Consulting fees$73,23971%
- Speaking & faculty fees$4,7475%
- Travel & lodging$24,28824%
- Food & beverage$5471%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 23 | $57,376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $24,084 |
| Shire North American Group Inc | 14 | $14,584 |
| Amicus Therapeutics, Inc. | 4 | $4,056 |
| Bioverativ Therapeutics Inc. | 2 | $2,298 |
| Ultragenyx Pharmaceutical Inc. | 1 | $400 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,821 in reported general payments places this provider in the 95th percentile of 161 neurology with special qualifications in child neurology providers in New York.
See all neurology with special qualifications in child neurology providers in New York →
Other neurology with special qualifications in child neurology in New York
- Claudia ChiribogaNew York$220K
- Kaleb YohayNew York$125K
- Darryl DevivoNew York$67K
- Mary Lynn ChuNew York$66K
- Gurcharanjeet KaurNew York$40K
- Jahannaz DastgirNew York$28K
- Naomi LubarrNew York$16K
- Tristan SandsNew York$12K
- Divya JayaramanNew York$10K
- Asim ShahidNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.